Resection or transplantation for hepatocellular carcinoma: is the decision clear for patients beyond Milan criteria?
作者信息
Kays Joshua K, Milgrom Daniel P, Koniaris Leonidas G
机构信息
Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA.
出版信息
Hepatobiliary Surg Nutr. 2017 Aug;6(4):284-286. doi: 10.21037/hbsn.2017.04.03.
Abstract
摘要
相似文献
1
Resection or transplantation for hepatocellular carcinoma: is the decision clear for patients beyond Milan criteria?肝细胞癌的切除术或移植术：对于超出米兰标准的患者，决策是否明确？
Hepatobiliary Surg Nutr. 2017 Aug;6(4):284-286. doi: 10.21037/hbsn.2017.04.03.
2
Liver Transplantation for Hepatocellular Carcinoma Beyond the Milan Criteria.超出米兰标准的肝细胞癌肝移植
Exp Clin Transplant. 2017 Mar;15(Suppl 2):59-64. doi: 10.6002/ect.TOND16.L16.
3
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.米兰标准以外的肝细胞癌患者的肝切除与肝移植
Ann Surg. 2016 Oct;264(4):650-8. doi: 10.1097/SLA.0000000000001866.
4
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.预测米兰标准以外的肝细胞癌患者肝移植后的生存率：一项回顾性探索性分析。
Lancet Oncol. 2009 Jan;10(1):35-43. doi: 10.1016/S1470-2045(08)70284-5. Epub 2008 Dec 4.
5
Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinoma.术前血小板与淋巴细胞比值可预测肝细胞癌患者肝切除术后超出米兰标准的复发情况。
Hepatol Res. 2017 Sep;47(10):991-999. doi: 10.1111/hepr.12835. Epub 2016 Dec 21.
6
Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.针对超出米兰标准的肝细胞癌进行肝移植
Gut. 2016 Jun;65(6):1035-41. doi: 10.1136/gutjnl-2014-308513. Epub 2015 Mar 24.
7
Liver resection versus liver resection plus TACE for patients with hepatocellular carcinoma beyond Milan criteria.对于超出米兰标准的肝细胞癌患者，肝切除术与肝切除术联合经动脉化疗栓塞术的比较
J Surg Res. 2017 Mar;209:8-16. doi: 10.1016/j.jss.2016.09.054. Epub 2016 Oct 4.
8
Role of Adult Living Donor Liver Transplantation in the Treatment of Hepatocellular Carcinoma Within and Beyond Milan Criteria: A Comparative Study.成人活体肝移植在米兰标准内外肝细胞癌治疗中的作用：一项比较研究。
Transplant Proc. 2018 Jun;50(5):1386-1395. doi: 10.1016/j.transproceed.2018.02.093.
9
Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions.扩大肝移植米兰标准在肝癌治疗中的应用：未来的方向。
World J Gastroenterol. 2018 Aug 28;24(32):3626-3636. doi: 10.3748/wjg.v24.i32.3626.
10
Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.超出米兰或加州大学旧金山分校标准的肝细胞癌活体肝移植结果
Indian J Surg. 2015 Dec;77(Suppl 3):950-6. doi: 10.1007/s12262-014-1078-6. Epub 2014 Apr 24.
引用本文的文献
1
Challenges in patient selection for liver resection or transplantation in patients with hepatocellular carcinoma beyond Milan criteria.超出米兰标准的肝细胞癌患者肝切除或肝移植的患者选择挑战。
Hepatobiliary Surg Nutr. 2017 Aug;6(4):287-289. doi: 10.21037/hbsn.2017.07.04.
本文引用的文献
1
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.米兰标准以外的肝细胞癌患者的肝切除与肝移植
Ann Surg. 2016 Oct;264(4):650-8. doi: 10.1097/SLA.0000000000001866.
2
Silencing porcine genes significantly reduces human-anti-pig cytotoxicity profiles: an alternative to direct complement regulation.沉默猪基因可显著降低人抗猪细胞毒性特征：一种直接补体调节的替代方法。
Transgenic Res. 2016 Oct;25(5):751-9. doi: 10.1007/s11248-016-9958-0. Epub 2016 Apr 21.
3
Silencing Porcine CMAH and GGTA1 Genes Significantly Reduces Xenogeneic Consumption of Human Platelets by Porcine Livers.沉默猪CMAH和GGTA1基因可显著降低猪肝对人血小板的异种消耗。
Transplantation. 2016 Mar;100(3):571-6. doi: 10.1097/TP.0000000000001071.
4
Liver transplantation versus liver resection in the treatment of hepatocellular carcinoma: a meta-analysis of observational studies.肝移植与肝切除术治疗肝细胞癌的比较：一项观察性研究的荟萃分析。
Transplantation. 2014 Jan 27;97(2):227-34. doi: 10.1097/TP.0b013e3182a89383.
5
A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group.在三级转诊中心，手术治疗肝细胞癌的有效适应证和结果概览：是否符合 EASL/AASLD 建议？：HCC 东西研究组的一项观察性研究。
Ann Surg. 2013 May;257(5):929-37. doi: 10.1097/SLA.0b013e31828329b8.
6
Is resection equivalent to transplantation for early cirrhotic patients with hepatocellular carcinoma? A meta-analysis.对于早期肝硬化合并肝细胞癌的患者，切除与移植等效吗？一项荟萃分析。
J Gastrointest Surg. 2012 Oct;16(10):1897-909. doi: 10.1007/s11605-012-1973-8. Epub 2012 Jul 27.
7
International trends in liver cancer incidence rates.全球肝癌发病率趋势。
Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2362-8. doi: 10.1158/1055-9965.EPI-11-0643. Epub 2011 Sep 15.
8
Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?手术切除在治疗肝细胞癌方面优于移植吗？
Ann Surg. 2011 Sep;254(3):527-37; discussion 537-8. doi: 10.1097/SLA.0b013e31822ca66f.
9
Molecular pathogenesis of hepatocellular carcinoma.肝细胞癌的分子发病机制
J Surg Res. 2006 Nov;136(1):125-35. doi: 10.1016/j.jss.2006.04.013. Epub 2006 Oct 3.
10
Liver regeneration.肝脏再生
J Am Coll Surg. 2003 Oct;197(4):634-59. doi: 10.1016/S1072-7515(03)00374-0.
Zotero 插件